Dr Michael Levy

Dr Michael Levy has resigned as VP research and chief medical office of Glaxo Wellcome Canada. Levy, considered one of the shining stars of the Canadian pharmaceutical sector, has accepted a position with Tularik Inc, a biotechnology firm based in San Francisco CA. Levy will assume the duties of VP development and chief medical officer, leading Tularik's development activities with a focus on new drug approvals. As a member of the senior management team, he will also play a role in the company's strategic direction. The new position represents a marked change from Levy's duties at Glaxo Wellcome, which were l